Julio Enrique Serrano Noguès
Direttore/Membro del Consiglio presso INBEST PRIME II INMUEBLES SOCIMI, S.A.
Profilo
Julio Enrique Serrano Noguès is currently the Chief Executive Officer at Palbox Holding Sl and Director at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Director at Inbest Prime II Inmuebles SOCIMI SA and Inbest Prime III Inmuebles SOCIMI SA. Mr. Serrano Noguès completed his undergraduate degree at the University of Valencia.
Posizioni attive di Julio Enrique Serrano Noguès
Società | Posizione | Inizio |
---|---|---|
INBEST PRIME II INMUEBLES SOCIMI, S.A. | Direttore/Membro del Consiglio | 13/05/2019 |
INBEST PRIME III INMUEBLES SOCIMI, S.A. | Direttore/Membro del Consiglio | 13/05/2019 |
Palbox Holding Sl | Amministratore Delegato | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Direttore/Membro del Consiglio | - |
Formazione di Julio Enrique Serrano Noguès
University of Valencia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INBEST PRIME II INMUEBLES SOCIMI, S.A. | Finance |
INBEST PRIME III INMUEBLES SOCIMI, S.A. | Finance |
Aziende private | 2 |
---|---|
Palbox Holding Sl | |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Julio Enrique Serrano Noguès